Bioabsorbable Stents Market to Surge to $1,426.3 Million by 2035 | Fact.MR

The global Bioabsorbable Stents Market is poised for remarkable growth, projected to expand from an estimated $540 million in 2025 to a staggering $1,426.3 million by 2035, according to a detailed report by Fact.MR. This robust growth, driven by a compound annual growth rate (CAGR) of 10.2%, highlights the increasing adoption of bioabsorbable stents as a revolutionary solution for treating cardiovascular diseases, fueled by technological advancements and a rising preference for minimally invasive procedures.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7375

Rising Cardiovascular Disease Prevalence Drives Demand

The escalating global burden of cardiovascular diseases (CVDs), particularly coronary artery disease (CAD), is a primary catalyst for the bioabsorbable stents market. According to the report, CVDs are the leading cause of mortality worldwide, with 17.9 million deaths annually, as reported by the World Health Organization. The growing incidence of CAD, coupled with risk factors such as obesity, diabetes, hypertension, and sedentary lifestyles, has heightened the need for advanced treatment options. Bioabsorbable stents, which dissolve naturally after restoring vessel patency, offer a compelling alternative to permanent metallic stents by reducing long-term complications such as late-stent thrombosis and restenosis.

The report emphasizes that the geriatric population, particularly those over 65, is more prone to CVDs due to age-related changes in blood vessels. In the United States, 10.9% of adults aged 45 and older are diagnosed with CAD, with prevalence rising to 17% among those over 65, according to the Centers for Disease Control and Prevention. This demographic trend is driving demand for bioabsorbable stents, which are particularly appealing for younger patients and those requiring long-term vessel health.

Technological Advancements Propel Market Growth

Innovations in material science and stent design are transforming the bioabsorbable stents market. The development of polymer-based stents, primarily using polylactic acid (PLA), has enhanced biocompatibility, mechanical strength, and controlled degradation timelines. These stents, coated with antiproliferative drugs or genes, dissolve gradually, minimizing complications like vessel irritation and inflammation. Recent advancements in drug-eluting mechanisms and scaffold design have addressed early challenges, such as insufficient radial strength and deliverability, improving clinical outcomes and restoring confidence among interventional cardiologists.

The report notes that second-generation bioabsorbable stents feature thinner struts, faster resorption times, and improved radial force, overcoming limitations of earlier models. For instance, Amaranth's Magnitude stent, with a strut thickness of 100 microns, exemplifies these advancements. The integration of biocompatible materials, such as aliphatic polyesters, polyorthoesters, and polyanhydrides, further enhances stent performance, making them a preferred choice for percutaneous coronary interventions (PCIs).

Regional Insights: North America and Europe Lead, Asia Pacific Gains Momentum

North America dominates the bioabsorbable stents market, driven by a high prevalence of CAD, advanced healthcare infrastructure, and favorable reimbursement policies. The United States, valued at $135.4 million in 2022, leads the region, supported by aggressive clinical research and rapid adoption of innovative stenting technologies. The FDA's accelerated approval pathways for bioresorbable scaffolds have facilitated market penetration, while substantial investments by medical device manufacturers bolster growth.

Europe holds a significant market share, with countries like Germany, France, and the United Kingdom at the forefront due to robust healthcare systems and a focus on minimally invasive procedures. The European Medicines Agency (EMA) has played a pivotal role in enabling access to next-generation stents through adaptive regulatory routes. Ongoing clinical trials evaluating long-term outcomes of bioabsorbable scaffolds align with Europe's emphasis on cost-effective and sustainable healthcare solutions.

Asia Pacific is emerging as a high-growth region, with China projected to reach a market value of $71.6 million by 2032. The region's growth is fueled by increasing healthcare expenditure, a rising burden of CVDs, and improving access to advanced medical technologies. Japan, with its large elderly population, is witnessing heightened demand for bioabsorbable stents as an alternative to traditional metallic implants.

Market Segmentation and Key Trends

The Fact.MR report segments the bioabsorbable stents market by material, absorption rate, application, end user, and region:

By Material: Bioabsorbable polymer-based stents dominate, driven by their biocompatibility and versatility. Poly-L-lactic acid (PLLA) and polyglycolic acid (PGA) are widely used, with ongoing research into polycaprolactone and copolymers to enhance performance. Bioabsorbable metallic stents are gaining traction as an alternative for specific applications.

By Absorption Rate: Slow-absorption stents lead the market, offering prolonged vessel support, while fast-absorption stents are preferred for specific clinical scenarios requiring quicker degradation.

By Application: The coronary artery disease segment is the fastest-growing, with a projected CAGR of 10.2%, reflecting the high prevalence of CAD globally. Peripheral artery disease applications are also expanding.

By End User: Hospitals account for the largest share, growing at a CAGR of 10.1%, due to advanced infrastructure and trained professionals. Cardiac centers and ambulatory surgical centers are also significant contributors.

By Region: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with North America and Europe leading in market share.

Key trends include the shift toward value-based care, increased adoption of minimally invasive PCIs, and growing patient preference for temporary implants. The report also highlights the role of clinical trials and regulatory approvals in building trust and expanding market access.

Browse Full Report: https://www.factmr.com/report/bioabsorbable-stents-market

Challenges and Opportunities

The bioabsorbable stents market faces challenges, including stringent regulatory requirements and safety concerns from early-generation devices. The 2017 recall of Abbott's Absorb stent due to higher rates of thrombosis and restenosis initially slowed adoption. However, advancements in design and materials have mitigated these risks, restoring clinician confidence. High device costs and the need for specialized surgeon training remain barriers, particularly in emerging economies.

Despite these challenges, the market offers significant opportunities. The growing preference for outpatient procedures, favorable reimbursement policies, and increasing healthcare investments in regions like Asia Pacific are driving growth. The development of hybrid stent designs and longer absorption periods presents new avenues for innovation, while collaborations between manufacturers and research institutions are accelerating product development.

Competitive Landscape and Strategic Developments

The bioabsorbable stents market is moderately competitive, with key players focusing on product innovation, mergers and acquisitions, and global expansion. Notable developments include:

Biotronik's Orsiro drug-eluting stent, approved by China's National Medical Products Administration in October 2019, features a bioabsorbable polymer coating for enhanced safety.

Arterius partnered with the University of Bristol's Translational Biomedical Research Centre in April 2019 to develop smart bioresorbable stents for peripheral vascular disease.

Leading companies, including Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, and Meril Life Sciences, are investing in R&D to introduce next-generation stents with improved safety and efficacy profiles. The report surveyed 13,200 stakeholders across 33 countries, including end users, manufacturers, and regulatory experts, to provide a comprehensive analysis of market dynamics.

Future Outlook

The bioabsorbable stents market is set for sustained growth through 2035, driven by the rising prevalence of CVDs, technological advancements, and a shift toward minimally invasive treatments. The integration of advanced materials, improved drug-eluting capabilities, and AI-driven stent design is expected to further enhance market potential. With an absolute dollar opportunity of $886.3 million over the forecast period, the bioabsorbable stents market represents a transformative segment in cardiovascular care, offering safer and more effective solutions for patients worldwide.

Check out More Related Studies Published by Fact.MR:

Arterial Stents Market: https://www.factmr.com/report/4713/arterial-stents-market

Coronary Stents Market: https://www.factmr.com/report/laryngeal-stents-market

Gastrointestinal Stents Market: https://www.factmr.com/report/gastrointestinal-stents-market

Biliary Stents Market: https://www.factmr.com/report/biliary-stents-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.